Discover how Primera- formulated by women's health experts Dr. T and Alex Miller-leverages a synergistic blend of plant-based ingredients to naturally support pelvic floor strength, bladder control, ...

Food and Drug Administration Commissioner Marty Makary promised stakeholders last week that the agency’s new Covid-19 vaccine ...

The US Food and Drug Administration (FDA) has approved the first-ever blood test to diagnose the debilitating Alzheimer's disease early. The US Food and Drug Administration (FDA) has approved the ...

The vaccine's prospects were thrown into doubt after the FDA missed its April 1 target to approve the shot, which is a more traditional protein-based vaccine unlike its messenger RNA-based rivals. US ...

Attorneys discuss ‘Loper Bright Enterprises v. Raimondo’ and its impact to medical patent cases. Many anticipated that Loper ...

Saptalis Pharmaceuticals Announces the Launch of LIKMEZ® — The First and Only US FDA-Approved Ready-to-Use Oral Suspension of Metronidazole Saptalis Pharmaceuticals LLC proudly announces the ...

Novavax, Inc. announced that the US Food and Drug Administration (FDA) has approved the Biologics License Application (BLA) for Nuvaxovid for active immunization to prevent coronavirus disease 2019 ...

The FDA has approved the Novavax Covid-19 vaccine, but with restrictions, limiting its use to older adults and those over 12 with high-risk medical conditions. This decision follows debates among ...

“It gives us hope, as volunteers ... Previously, the only FDA-approved methods for detecting amyloid were invasive tests of spinal fluid or expensive PET scans. DiBrango says there is no ...

(Reuters) -The U.S. Food and Drug Administration has cleared Fujirebio Diagnostics' blood test to diagnose Alzheimer's disease, the regulator said on Friday, making the device the first of its ...

(Reuters) -The U.S. Food and Drug Administration has cleared Fujirebio Diagnostics' blood test to diagnose Alzheimer's disease, the regulator said on Friday, making the device the first of its kind to ...

The U.S. FDA approved 20 drugs for market in April, slightly down from 22 in March, 16 in February and 12 in January. This brings the total number of FDA approvals for the first four months of 2025 to ...